News Posts matching 'NHSlongtermplan'
Aseptika named as one of four Medtech Companies to Watch: Most exciting respiratory disease technology companies in Europe
A new report “Counting the Cost of Respiratory Disease”, by Health Enterprise East, has named Aseptika as one of four Medtech companies to watch.
Posted on February 10, 2020
Don’t blame kids with asthma for polluting the environment with their inhalers
PRESS COMMENT 31st October 2019: Aseptika Limited (Activ8rlives), Cambridgeshire, UK 1.1 million of the UK’s children have asthma. 10% have moderate-to-severe asthma and these children should be treated by specialist paediatricians, expert in controlling what can be a life-threatening condition. Widely reported in the media on 30th October 2019 (BBC, Daily Mail, Telegraph) is the […]
Posted on October 31, 2019
Activ8rlives⁴ Health+Wellbeing App by Aseptika achieves CE mark as a medical device
Activ8rlives4 Health+Wellbeing App by Aseptika achieves CE mark as a Class 1 medical device.
Posted on January 14, 2019